In EC, computational analysis of RNAseq data deposited in the TCGA database show that COL9A1 expression is increased both in primary and metastatic tumor (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173926/) accessed on 4 July 2022. This evidence concerns the gene COL9A1 and metastatic neoplasm.